期刊文献+

热休克蛋白在喉癌中的表达 被引量:14

Expression of heat shock proteins in laryngeal carcinoma
下载PDF
导出
摘要 目的探讨热休克蛋白(heatshockproteins,HSPs)在喉癌组织及其正常喉粘膜中的表达。方法采用狭缝杂交(Slotblotanalysis)技术对21例喉癌组织及其正常喉粘膜的HSP90、HSP70和HSP27mRNA表达水平进行检测。结果①HSP90α和HSP70在喉癌组织中呈过度表达,表达量是自身正常喉粘膜的5倍以上。②HSP27和HSP90β在喉癌组织及正常喉粘膜中呈低水平表达,其表达量在两种组织中差异无显著性。结论HSP70和HSP90α在喉癌的致病过程中起着重要的作用。弄清它们的作用机理,将为HSPs用于喉癌的生物治疗提供理论依据。 Objective To determine the expression of HSPs(HSP90α, HSP90β , HSP70, HSP27) in laryngeal carcinoma and normal laryngeal mucosa. Methods Total RNA were extracted from 21 laryngeal cancer tissue samples and the normal mucosa of the corresponding larynx. The expression of HSPs mRNA was examined by Slot blot analysis. Results ①HSP90 α and HSP70 were selectively overexpressed 5 times more in laryngeal carcinoma than in normal mucosa of larynx. ②HSP90 β and HSP27 were constitutively expressed at low level in these two groups. There was no significant difference between the levels of expression of HSP90 β and HSP27 in laryngeal carcinoma and normal controls. Conclusion The results that HSP90 α and HSP 70 mRNA were selectively overexpressed in laryngeal carcinoma suggested that HSP90α and HSP70 might play a specific role in the pathogenesis of laryngeal cancer.To clarify the mechanism of HSPs action could help to provide theorical basis for the biological therapy of laryngeal cancer.
出处 《中华耳鼻咽喉科杂志》 CSCD 1998年第4期232-233,共2页 Chinese Journal of Otorhinolaryngology
基金 卫生部医学科学研究基金
关键词 喉肿瘤 热休克蛋白 基因表达 Laryngeal neoplasms Heatshock proteins Gene expression
  • 相关文献

同被引文献88

  • 1张继红,佟海侠,滕绍春,张可仞,张锦华.Caspase8在实验性神经母细胞瘤细胞凋亡中作用的研究(英文)[J].中国现代医学杂志,2006,16(13):1921-1925. 被引量:5
  • 2CHANG HC, WENG CF. Cyclooxygenase-2 level and culture conditions influence NS398-induced apoptosis and caspase activation in lung cancer cells [J]. Oncol Rep, 2001, 8 (6): 1321-1325.
  • 3PYO H, CHOY H, AMORINO GP, et al. Selective Cyclooxygenase-2 inhinitor, NS-398, enhances the effects of radiation in vitro and in vivo preferentially on the cells that express Cyclooxygenase-2[J]. Clin Cancer Res, 2001, 7(10): 2998-3005.
  • 4SORIANO AF, HELFRICH B, CHAN DC, et al. Synergistic effects of new chemopreventive agents and conventional cytotoxic agents against human lung cancer cell lines [J]. Cancer Res, 1999, 59(24): 6178-6184.
  • 5CHOU TC, TALALAY P. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors[J]. Adv Enzyme Regul, 1984, 22: 27-55.
  • 6GM KOLFSCHOTEN, TM HULSCHER, HM PINEDO, et al.Drug resistance features and S-phase fraction as possible determinants for drug response in a panel of human ovarian cancer xenografts[J]. British Joumal of cancer, 2000, 83(7): 921-927.
  • 7CHEVILLARD S, POUILLART P, BELDJORD C, et al. Sequential assessment of muhidrug resistance phenotype and measurement of S-phase fraction as predivtive markers of breast cancer response to neoadjunct chemotherapy[J]. Cancer, 1996, 77: 292-300.
  • 8LIU X, YE L, WANG J, FAN D. Expression of heat shock protein 90 beta in human gastrie cancer tissue and SGC7901/VCR of MDR-type gastric cancer cell line {J]. Chin Med J (Engl), 1999, 112(12): 1133-1137.
  • 9WATABA K, SAITO T, FUKUNAKA K, et al. Over-expression of heat shock proteins in carcinogenic endometrium [J]. Int J Cancer, 2001, 91(4): 448-456.
  • 10VANDEN BERGHE T, KAHAI M, VAN LOO G, et al. Disruption of HSP90 function revers tumor necrosis factor-induced necrosis to apoptosis[J]. J Biol Chem, 2003, 278(8): 5622-5629.

引证文献14

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部